J&J Tries To Ease EU Concerns Over $21B Synthes Deal

Law360, New York (February 22, 2012, 6:03 PM EST) -- Johnson & Johnson has offered unnamed concessions meant to ease the European Commission's antitrust concerns over the company's proposed $21.3 billion acquisition of leading orthopedic device maker Synthes Inc., the regulator said on Wednesday.

While the EC did not offer any additional details about the companies' proposed concessions, submitted to the regulator on Tuesday, it did extend the commission's deadline to rule on the planned deal by 15 days until Apr. 26.

Antoine Colombani, spokesman for the commission's competition department, confirmed Wednesday that J&J's offer of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.